Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Insmed Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 12:30AM GMT
Release Date Price: $18.92 (+6.35%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Welcome, everyone. Good afternoon. My name is Jess Fye. I'm the large cap biotech analyst at JPMorgan, and we're continuing the conference today with Insmed.

Good news. We don't have to switch rooms for Q&A this year. So we're all going to stay here after the presentation and go straight into Q&A. If you want to ask a question, there's 2 ways you can do it. You can raise your hand, somebody will bring you a mic or you can type your question into the portal, it'll shoot it to an iPad I'll have up there, and I can read your questions that way.

So with that, let me turn it over to Insmed's CEO, Will Lewis.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Thank you, Jess. One second for a technical adjustment. I'll give you a preview. I'm anxious to share what's going on with the company, but in a moment, I'm going to have to put up our forward-looking slide -- forward-looking statements slide.

I will be making some forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot